ZBIO vs OCUL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 29, 2026

ZBIO

53.1
AI Score
VS
OCUL Wins

OCUL

59.2
AI Score

Investment Advisor Scores

ZBIO

53score
Recommendation
HOLD

OCUL

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZBIO OCUL Winner
Revenue 10.00M 10.79M OCUL
Net Income -33.57M -88.61M ZBIO
Net Margin -335.7% -821.6% ZBIO
Operating Income -37.33M -93.34M ZBIO
ROE -11.8% -15.2% ZBIO
ROA -10.1% -12.1% ZBIO
Total Assets 333.77M 732.53M OCUL
Cash 196.55M 666.70M OCUL
Current Ratio 6.47 14.81 OCUL
Free Cash Flow -37.07M -70.66M ZBIO

Relative Price Performance (Last 90 Days)

ZBIO 1M: +14.3% · 3M: +60.8% OCUL 1M: -12.9% · 3M: -10.9%

Current Technical Phase

ZBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.4% over 20 days), RSI 59

RSI (14): 59.3 · Price: $31.13

OCUL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.5%), weak momentum, RSI 40

RSI (14): 40.1 · Price: $8.40

Fundamentals Snapshot

Metric ZBIO OCUL
Market Cap
Forward P/E -13.7 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin -3.4%
Operating Margin 0.0% -8.7%
EPS -9.10 -1.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, OCUL is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.